Asia-Pacific minimally invasive surgical instruments market is expected to grow at a CAGR of around 8.6% during the forecast period. Asia Pacific minimally invasive surgical instruments market is expected to grow significantly owing to increasing prevalence of CVD diseases and significant rise in ageing population in the country. According to UN ESCAP (United Nations Economic and Social Commission for Asia and the Pacific), in 2016, nearly 12.4% of the population in APAC was 60 years and above. However, it is projected to rise to more than a quarter or 1.3 billion people by 2050.
In East and North Asia (including countries with significant ageing population such as Japan and the Republic of Korea), more than a third of the population is expected to be aged 60 years and above by 2050, however in North and Central Asia, one in four persons will be 60 years and above. Additionally, the older population in less developed regions are growing rapidly as compared to more developed regions. By 2050, approximately 8 in 10 people of the world’s older population is expected to live in less developed regions. Growing ageing population leads to significant rise in multiple diseases, including orthopedic, heart disease, cataract and Alzheimer’s. This results in fueling the adoption of minimally invasive surgeries to offer effective outcomes for patients and further encouraging the demand for MIS instruments in the region.
The major companies operating in the market comprise Abbott Laboratories, Inc., Boston Scientific Corp., Medtronic plc, Koninklijke Philips N.V., and Olympus Corp. These companies are adopting several strategies, including mergers and acquisitions, product launches, and partnerships and collaborations, to expand market share and gain a competitive advantage over their competitors. The platforms offered by these companies are significantly adopted in hospitals to efficiently perform minimally invasive procedures. In August 2019, Asian Hospital and Medical Center’s (AHMC) introduced its Catheterization Lab which includes next-generation image-guided therapy platform, Philips Azurion 7 C20. This platform allows clinicians to perform open and minimally invasive procedures in one room. This shows increasing preference towards minimally invasive procedures, which is supporting to drive the growth of the market in the region.
Research Methodology
The market study of the Asia-Pacific minimally invasive surgical instruments market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders and industry experts. Primary research brings authenticity in our reports.
Secondary Sources Include:
The report provides an in-depth analysis of pricing, market size, intended quality of the product preferred by consumers. It will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.
Market Segmentation:
The Report covers:
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Country
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. Asia-Pacific Minimally Invasive Surgical Instruments Market by Product
5.1.1. Inflation Systems
5.1.2. Cutter Instruments
5.1.3. Guiding Devices
5.1.4. Handheld Instruments
5.1.5. Stents
5.1.6. Sutures
5.1.7. Monitoring and Visualization Equipment
5.1.8. Robotic Assisted Surgical Systems
5.2. Asia-Pacific Minimally Invasive Surgical Instruments Market by Technology
5.2.1. Endoscopy
5.2.2. Laparoscopy
5.2.3. Robot-Assisted Methods
5.2.4. Arthroscopic Techniques
5.2.5. Ablative Methods
5.3. Asia-Pacific Minimally Invasive Surgical Instruments Market by Application
5.3.1. Cardiac Surgery
5.3.2. Colorectal Surgery
5.3.3. Dermatological Surgery
5.3.4. ENT Surgery
5.3.5. Gastrointestinal Surgery
5.3.6. Gynecological Surgery
5.3.7. Lung & Respiratory Care
5.3.8. Neurosurgery
5.3.9. Ophthalmology
5.3.10. Orthopedics
5.3.11. Others
6. Regional Analysis
6.1. China
6.2. India
6.3. Japan
6.4. Rest of Asia-Pacific
7. Company Profiles
7.1. Abbott Laboratories, Inc.
7.2. Boston Scientific Corp.
7.3. Edwards Lifesciences Corp.
7.4. Johnson & Johnson Services, Inc.
7.5. Koninklijke Philips N.V.
7.6. Medtronic plc
7.7. Olympus Corp.
7.8. Teleflex, Inc.
7.9. Terumo Medical Corp.
7.10. Zimmer Biomet Holdings, Inc.
1. ASIA-PACIFIC MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
2. ASIA-PACIFIC MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2018-2025 ($ MILLION)
3. ASIA-PACIFIC MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2018-2025 ($ MILLION)
4. ASIA-PACIFIC MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
1. ASIA-PACIFIC MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SHARE BY COUNTRY, 2018 VS 2025 (%)
2. ASIA-PACIFIC MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SHARE BY PRODUCT, 2018 VS 2025 (%)
3. ASIA-PACIFIC MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SHARE BY TECHNOLOGY, 2018 VS 2025 (%)
4. ASIA-PACIFIC MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SHARE BY APPLICATION, 2018 VS 2025 (%)
5. CHINA MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, 2018-2025 ($ MILLION)
6. INDIA MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, 2018-2025 ($ MILLION)
7. JAPAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, 2018-2025 ($ MILLION)
8. REST OF ASIA-PACIFIC MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, 2018-2025 ($ MILLION)